Expert insight on testing for rheumatoid arthritis

Read an article from one of our rheumatology experts on novel blood tests for rheumatoid arthritis and the need for more RA biomarkers.


Read more

Discover Care360®—A complete healthcare IT solution

More than 300,000 providers use the Care360 platform to manage patient data, connect with their community network and improve care coordination.


Read more

Quest Diagnostics Health Trends™

In Allergies Across America, Quest Diagnostics provides results of the largest analysis of allergy testing on patients in the US who are under medical evaluation for symptoms associated with allergies. Read the full report.


Read more

Care360® EHR

In this 1-minute video, Boston-area neurologist Paulo Andre, MD shares how Care360 EHR helps him easily obtain and share medical information across three hospitals, from any location.


Read more

ImmunoCAP® specific IgE blood test

ImmunoCAP provides a clinically relevant means of identifying specific allergen sensitivities in patients with a confirmed allergy. Learn more.


Read more

Meet 14-3-3ŋ (eta), a biomarker for RA

Dr. Walter Maksymowych of the University of Alberta discusses the pathophysiology of 14-3-3ŋ (eta), an inflammatory mediator with diagnostic and prognostic value for rheumatoid arthritis, as well as a new assay that measures 14-3-3ŋ.


Read more

Prescription Drug Monitoring: available tests

Check our comprehensive menu of clinical drug monitoring tests to learn whether the therapies you prescribe are included.


Read more

Which arthritis biomarkers?

Watch as a rheumatology expert compares rheumatoid arthritis (RA) and osteoarthritis (OA), the difficulty of differential diagnosis, and how the limitations of current antibody biomarkers can be overcome by the 14-3-3ŋ (eta) biomarker.


Read more

Prescription Drug Monitoring: tests & services

Discover the range of clinical drug monitoring services available from Quest, including medMATCH® reports and Quanum™ solutions.


Read more

Know a more comprehensive story: the role of injury and inflammation in cardiovascular disease risk

See how lipoprotein risk factors and inflammatory markers can offer you deeper insight into a patient's risk for cardiovascular disease progression in this useful infographic.


Read more
email icon

Subscribe to Primary Insights

Get the clinical insights most relevant to you and your patients, from the lab committed to knowing.